BioCentury | Oct 13, 2018
Product Development

Bourla’s breadcrumbs to value

...A) In 2010, revenues from Biopharmaceuticals unit only, excluding consumer health, animal health, nutrition and Capsugel...
BioCentury | May 16, 2016
Clinical News

Buprenorphine hemiadipate: Phase I data

...RBP-6300 ) Business: Neurology Molecular target: NA Description: Abuse-deterrent tablet formulation of buprenorphine using Capsugel...
BioCentury | Feb 22, 2016
Company News

Capsugel, Pulmatrix deal

...therapeutic candidates for pulmonary diseases and to manufacture clinical and commercial batches of those therapeutics. Capsugel...
...with Pulmatrix’s iSPERSE (inhaled small particles easily respirable and emitted) dry powder inhalational delivery technology. Capsugel...
...uses Pulmatrix’s iSPERSE drug delivery platform. The companies declined provide further details or financial terms. Capsugel Inc....
BioCentury | May 12, 2014
Strategy

Build up to break up

...down, spinning out one business and selling off two others. In 2011, Pfizer sold its Capsugel...
BioCentury | Sep 16, 2013
Company News

Bend Research, Capsugel deal

...business unit. Capsugel said Bend's bioavailability enhancement, particularly its spray-dried dispersion (SDD) technology, will complement Capsugel...
...month. The companies could not be reached for details. Bend Research Inc. , Bend, Ore. Capsugel Inc....
BioCentury | Jul 2, 2012
Company News

Capsugel, Quotient Bioresearch deal

...combine its RapidFACT real time clinical manufacturing and testing services with lipid-based formulation capabilities from Capsugel...
...formulations of poorly soluble molecules with limited oral bioavailability. Under the deal, Quotient will use Capsugel's...
...facility. Investment firm Kohlberg Kravis Roberts & Co. L.P. (NYSE:KKR, New York, N.Y.) acquired the Capsugel...
BioCentury | Oct 24, 2011
Finance

Abbott's bit parts

...launched in July. BMS isn't the only pharma dismantling non-core businesses. Pfizer Inc. sold its Capsugel...
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...recent examples, AstraZeneca sold its Astra Tech AB dental and urological business. Pfizer sold its Capsugel...
BioCentury | Aug 8, 2011
Company News

Pfizer, Kohlberg Kravis Roberts deal

...Pfizer completed its previously announced sale of its Capsugel business to investment firm Kohlberg Kravis Roberts...
BioCentury | Apr 11, 2011
Company News

Pfizer, Kohlberg Kravis Roberts deal

...its Capsugel business to investment firm Kohlberg Kravis Roberts for about $2.4 billion in cash. Capsugel...
Items per page:
1 - 10 of 17
BioCentury | Oct 13, 2018
Product Development

Bourla’s breadcrumbs to value

...A) In 2010, revenues from Biopharmaceuticals unit only, excluding consumer health, animal health, nutrition and Capsugel...
BioCentury | May 16, 2016
Clinical News

Buprenorphine hemiadipate: Phase I data

...RBP-6300 ) Business: Neurology Molecular target: NA Description: Abuse-deterrent tablet formulation of buprenorphine using Capsugel...
BioCentury | Feb 22, 2016
Company News

Capsugel, Pulmatrix deal

...therapeutic candidates for pulmonary diseases and to manufacture clinical and commercial batches of those therapeutics. Capsugel...
...with Pulmatrix’s iSPERSE (inhaled small particles easily respirable and emitted) dry powder inhalational delivery technology. Capsugel...
...uses Pulmatrix’s iSPERSE drug delivery platform. The companies declined provide further details or financial terms. Capsugel Inc....
BioCentury | May 12, 2014
Strategy

Build up to break up

...down, spinning out one business and selling off two others. In 2011, Pfizer sold its Capsugel...
BioCentury | Sep 16, 2013
Company News

Bend Research, Capsugel deal

...business unit. Capsugel said Bend's bioavailability enhancement, particularly its spray-dried dispersion (SDD) technology, will complement Capsugel...
...month. The companies could not be reached for details. Bend Research Inc. , Bend, Ore. Capsugel Inc....
BioCentury | Jul 2, 2012
Company News

Capsugel, Quotient Bioresearch deal

...combine its RapidFACT real time clinical manufacturing and testing services with lipid-based formulation capabilities from Capsugel...
...formulations of poorly soluble molecules with limited oral bioavailability. Under the deal, Quotient will use Capsugel's...
...facility. Investment firm Kohlberg Kravis Roberts & Co. L.P. (NYSE:KKR, New York, N.Y.) acquired the Capsugel...
BioCentury | Oct 24, 2011
Finance

Abbott's bit parts

...launched in July. BMS isn't the only pharma dismantling non-core businesses. Pfizer Inc. sold its Capsugel...
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...recent examples, AstraZeneca sold its Astra Tech AB dental and urological business. Pfizer sold its Capsugel...
BioCentury | Aug 8, 2011
Company News

Pfizer, Kohlberg Kravis Roberts deal

...Pfizer completed its previously announced sale of its Capsugel business to investment firm Kohlberg Kravis Roberts...
BioCentury | Apr 11, 2011
Company News

Pfizer, Kohlberg Kravis Roberts deal

...its Capsugel business to investment firm Kohlberg Kravis Roberts for about $2.4 billion in cash. Capsugel...
Items per page:
1 - 10 of 17